161 related articles for article (PubMed ID: 3012397)
1. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
Fischel SV; Medzihradsky F
Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
[TBL] [Abstract][Full Text] [Related]
2. Resolution in the receptor binding of putative mu and kappa opiates.
Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of opioid receptor binding in brain slices.
Barchfeld-Rothschild CC; Medzihradsky F
J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
[TBL] [Abstract][Full Text] [Related]
4. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
[TBL] [Abstract][Full Text] [Related]
6. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
7. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
[TBL] [Abstract][Full Text] [Related]
8. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
Tam SW
Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
[TBL] [Abstract][Full Text] [Related]
9. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
Gouardéres C; Audigier Y; Cros J
Eur J Pharmacol; 1982 Mar; 78(4):483-6. PubMed ID: 6281039
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
Weyhenmeyer JA; Mack KJ
Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
Tiberi M; Magnan J
Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
[TBL] [Abstract][Full Text] [Related]
12. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
[TBL] [Abstract][Full Text] [Related]
13. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
Delay-Goyet P; Roques BP; Zajac JM
Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
15. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
16. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
17. Computer modeling of subtypes of kappa opioid receptors in adrenal medulla.
Pesce GO; Cruciani RA; Munson PJ; Rodbard D
Eur J Pharmacol; 1990 Jul; 182(3):429-39. PubMed ID: 2171945
[TBL] [Abstract][Full Text] [Related]
18. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
Nock B; Rajpara A; O'Connor LH; Cicero TJ
Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
[TBL] [Abstract][Full Text] [Related]
19. Effects of guanyl nucleotides and ions on kappa opioid binding.
Mack KJ; Lee MF; Weyhenmeyer JA
Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712
[TBL] [Abstract][Full Text] [Related]
20. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
